Marc Scheineson is quoted on how the U.S. Food and Drug Administration can use the “generally recognized as safe” affirmation process to prove the safety of cannabidiol products.
In the News
August 6, 2019
Inside Health Policy | Gottlieb, Experts: Industry Can Use NDIs, Petitions to Show CBD Safety
Media Contact